Aurobindo Pharma Q2 net profit rises 8.6% to Rs 817 crore in Q2FY25
The company posted net profit of Rs 752 crore in the corresponding quarter of previous year. On a quarter-on-quarter (QoQ) basis the net profit declined 11%.
Revenue from operations increased by 8% YoY to Rs 7,796 crore in Q2FY25
On a QoQ basis revenue rose 3%.
The earnings before interest, tax, depreciation and ammortisation (EBITDA) before forex and other income rose 11.6% to Rs 1566 crore. The EBITDA margin for the quarter increased 65 basis points YoY to 20.1%.
Stock Trading
Options Scalping Made Easy
By — Sivakumar Jayachandran, Ace Scalper
Stock Trading
Renko Chart Patterns Made Easy
By — Kaushik Akiwatkar, Derivative Trader and Investor
Stock Trading
Introduction to Technical Analysis & Candlestick Theory
By — Dinesh Nagpal, Full Time Trader, Ichimoku & Trading Psychology Expert
Stock Trading
RSI Made Easy: RSI Trading Course
By — Souradeep Dey, Equity and Commodity Trader, Trainer
Stock Trading
Options Trading Course For Beginners
By — Chetan Panchamia, Options Trader
Stock Trading
RSI Trading Techniques: Mastering the RSI Indicator
By — Dinesh Nagpal, Full Time Trader, Ichimoku & Trading Psychology Expert
Stock Trading
Technical Analysis for Everyone — Technical Analysis Course
By — Abhijit Paul, Technical Research Head, Fund Manager- ICICI Securities
Stock Trading
Candlesticks Made Easy: Candlestick Pattern Course
By — elearnmarkets, Financial Education by StockEdge
Stock Trading
Market 101: An Insight into Trendlines and Momentum
By — Rohit Srivastava, Founder- Indiacharts.com
Stock Trading
ROC Made Easy: Master
